Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare... see more

NDAQ:INM - Post Discussion

InMed Pharmaceuticals Inc > Inmed Webinar
View:
Post by Stevemin on Apr 14, 2021 3:30pm

Inmed Webinar

April 28th Inmed (Adams and Colwill) will be doing a "webinar" through Edison (remember, Inmed PAYS Edison for their coverage).

They say they are going to give an "overview of the company's recent operating and financial activiites followed by a brief Q&A session".

The timing of this makes no sense. They are due to report qtrly numbers just a couple of weeks after this, why not wait until then to regurgitate the same old BS?? Why a "brief" Q&A session? Well because these questions will all be pre determined -- there's no way either of these two guys will take an off the cuff question because they know precisely how pissed off their shareholders are and won't dare engage with them.
This is just an attempt to placate shareholders and make us feel like they are finally listening to  and answering questions that have gone unanswered for months (and years).

I have no idea what they could possibly says that hasnt been said already - unless they announce they are doing another cap raise!! With Adams, you just never know. And Colwill is so arrogant and patronizing that there's no way you'll get anything useful from him. This webinar will be a huge waste of time.....

HEY ADAMS - How about you focus on stopping this years long epic destruction of shareholder value?? It is time for you to go.
Comment by gainwidpatience on Apr 14, 2021 9:07pm
I read an article this morning where the analyst issued a Neutral rating for Inmed with a statement - Company 'survived' by direct offerings. It is really concerning as all they have done so far is back to back raise, attending webinars, taking hefty compensation with out much progress.  On top of that, they are hiring Senior Director for investor relations. It is so funny that last ...more